Cardinal Health stock pre-market at EUR 208.10: plus 0.39 percent
Published on 10/07/2026 at 07:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cardinal Health stock is at EUR 208.10 in pre-market trading at Lang & Schwarz at 7:47 a.m. CEST on October 7, 2026. The price is up EUR 0.80, or 0.39 percent, versus the Lang & Schwarz prior close of EUR 207.30 on October 6, 2026.
Pre-market price
Lang & Schwarz lists a bid of EUR 206.80 and an ask of EUR 209.40. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Cardinal Health stock.
Previous close
The Lang & Schwarz prior close was EUR 207.30 on October 6, 2026. The current pre-market price is EUR 0.80 above that reference level.
CVS Health agreement extension
Cardinal Health said on October 1, 2026, that it had entered into a binding letter of intent to extend its existing pharmaceutical distribution agreement with CVS Health through June 30, 2032. The company said the extension would continue its current scope of distribution services. The announcement was published by Cardinal Health Newsroom.
In connection with the renewal, Cardinal Health reaffirmed fiscal 2027 non-GAAP earnings-per-share guidance of 13 percent to 15 percent growth, or $12.40 to $12.60. The company also reaffirmed long-term non-GAAP earnings-per-share growth guidance of 12 percent to 14 percent, according to the company release.
Upcoming results
Cardinal Health plans to release its fiscal 2027 first-quarter results on November 5 before trading opens on the New York Stock Exchange. The company said it will webcast a discussion of the results at 8:30 a.m. Eastern, as reported by Cardinal Health Newsroom.
